MCRB SERES THERAPEUTICS INC Earnings Reports 8-K Filing 2024 - Financial Results Announcement Seres Therapeutics, Inc. announced preliminary financial results for Q4 2023 with net sales of $10.4 million and cash of $128 million as of December 31, 2023.Get access to all SEC 8-K filings of the SERES THERAPEUTICS INC